Navigation Links
Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
Date:1/23/2008

- Leukine lyophilized formulation temporarily reserved for patients with

Acute Myelogenous Leukemia (AML) and those experiencing bone marrow

transplantation graft failure or engraftment delay - Bayer will replace current 500 mcg liquid formulation; aims to restore US

supplies of Leukine to current levels as quickly as possible

WAYNE, N.J., Jan. 23 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today, following consultation with the United States Food and Drug Administration (FDA), that it will withdraw the current liquid formulation of Leukine(R) marketed in the US. This decision was made in light of an upward trend in spontaneous reports of adverse reactions, including syncope (fainting), which are temporally correlated with the liquid Leukine 500 mcg vial which currently contains EDTA (edetate disodium).

While Bayer works to increase supplies of lyophilized Leukine and reformulate the liquid Leukine (to eliminate EDTA), Bayer will establish a special access program for the currently marketed lyophilized Leukine 250 mcg vial which does not contain EDTA. The upward trend in adverse event reporting rates is only associated with the Leukine liquid 500 mcg vial containing EDTA. Bayer has not observed an upward trend in reporting rates of these adverse events in the marketed Leukine 250 mcg lyophilized vial which does not contain EDTA. These adverse reactions are listed in the Leukine prescribing information.

The special access program is designed to prioritize the supply of the lyophilized Leukine for patients with Acute Myelogenous Leukemia (AML) and those who are experiencing bone marrow transplantation engraftment failure or delay. Leukine is the only myeloid growth factor approved to reduce the incidence of infections resulting in early death following induction chemotherapy in older adults with AML and to prolong survival of patients with bone marrow graft failure or engraftment delay, as co
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
2. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools
3. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools
4. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Northern New Jersey Elementary and Middle Schools
5. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools
6. AUDIO from Medialink and Bayer: Use Caution When Choosing Your Cold Medicine
7. Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products
8. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
9. Bayer Awards Making Science Make Sense Grant to Girl Scouts
10. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
11. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... using technology developed at Case Western Reserve University,s ... of Engineering, has made available avatarsvirtual patientsto train ... and others training to evaluate speech-language disorders to ... on the trainee, because a diagnosis doesn,t have ... , Graduate students studying to become speech-language pathologists ...
(Date:6/18/2013)... Angeles, CA (PRWEB) June 18, 2013 The ... entitled “The Cheater’s Guide to Getting Beach Ready,” offers a ... ready to look their best in a bathing suit this ... , skin firming , smoothing cellulite , and ... Dr. Simon Ourian, Medical Director of Epione Beverly Hills, “though ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, ... a second session of a silicone treatment for gluteus augmentation ... was allegedly performed by a mystery Venezuelan doctor in a ... to Dr. Bernabe Vazquez of Bayshore Cosmetic Surgery , ... doctor’s who are not board certified is more common than ...
(Date:6/18/2013)... June 18, 2013 Today, Zane Benefits, ... Reimbursement Accounts . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, employees of a company who sets up ... questions about how Health Reimbursement Accounts work. Educating employees ...
(Date:6/18/2013)... June 18, 2013 New York magazine named ... to its “Best Doctors” list, up from 129 last year ... The new issue also lists 52 additional doctors who serve ... a strategic growth trajectory. The “Best Doctors” issue, which this ... June 24 print issue and is available online at ...
Breaking Medicine News(10 mins):Health News:SimuCase avatars advance speech-language pathology training 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3
... , , NEW YORK, Sept. 21 ... Investor/Analyst Day on Tuesday, September 22nd in New York City beginning at ... , Discussing Perifosine Phase 3 SPA in Multiple ... Director, Jerome Lipper Multiple Myeloma Center and Chief, Division of ...
... , WASHINGTON, Sept. 21 /EIN News/ ... about to reveal that during the Clinton administration Philip Morris "worked ... health care reform which would have been partly funded by a ... is also credited with inventing the term "death panels" used by ...
... MORRISTOWN, N.J., Sept. 21 Watson ... and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson ... In this newly expanded position Mr. Wilkinson will be ... business, including brand product development, global sales and marketing and ...
... MIAMI, Sept. 21 In a category that seems to be ... announce that it has won " Best New Functional Drink" at ... Beverage Industry. NGW beat out 38 other competitors from 12 different countries ... name a few. , , The show was ...
... , TROY, Mich., Sept. 21 Somanetics Corporation (Nasdaq: SMTS ) today ... the following conferences: , , , UBS Global Life ... a.m. ( ET) , Grand Hyatt, New York, NY , , , ... Tuesday, September 29, 2009 , 9:00 a.m. (ET) , Grand Hyatt, New York, NY ...
... , , ... KG ) today announced a true milestone as it ... and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II ... when a continuous, around-the-clock opioid analgesic is needed for an ...
Cached Medicine News:Health News:Keryx Biopharmaceuticals, Inc. to Hold Investor/Analyst Day Tomorrow 2Health News:Keryx Biopharmaceuticals, Inc. to Hold Investor/Analyst Day Tomorrow 3Health News:'Death Panel' Inventor & Critic of Healthcare Reform Betsy McCaughey 'Has Close Ties' to Philip Morris; Healthcare Industry Today Offers Complete Coverage 2Health News:Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands 2Health News:Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands 3Health News:Florida-Based Small Business, Next Generation Waters, Beats Out Big Name Competitors at the 2009 Beverage Innovation Awards 2Health News:Somanetics Corporation To Present at UBS Global Life Sciences Conference and Maxim Group Growth Conference 2Health News:King Announces Commercial Availability of EMBEDA(TM) 2Health News:King Announces Commercial Availability of EMBEDA(TM) 3Health News:King Announces Commercial Availability of EMBEDA(TM) 4Health News:King Announces Commercial Availability of EMBEDA(TM) 5Health News:King Announces Commercial Availability of EMBEDA(TM) 6Health News:King Announces Commercial Availability of EMBEDA(TM) 7Health News:King Announces Commercial Availability of EMBEDA(TM) 8Health News:King Announces Commercial Availability of EMBEDA(TM) 9Health News:King Announces Commercial Availability of EMBEDA(TM) 10Health News:King Announces Commercial Availability of EMBEDA(TM) 11
(Date:6/18/2013)... , June 18, 2013 The board ... LLY ) has declared a dividend for the ... outstanding common stock. The dividend is ... the close of business on August 15, 2013. ... growing portfolio of pharmaceutical products by applying the latest ...
(Date:6/18/2013)... SALT LAKE CITY , June 18, 2013 ... registry-based informatics products for healthcare and life sciences ... U.S. General Services Administration (GSA) IT Schedule 70 ... is now certified to provide innovative IT solutions ... levels. In accordance with this contract, Remedy has ...
(Date:6/18/2013)...   Polymer Technology Systems, Inc. (PTS) ... to integrate the CardioChek ® PA ... health systems across the country. The CardioChek PA ... through Hanson Medical Systems , offers immediate, ... cholesterol, triglycerides, and glucose. (Logo: ...
Breaking Medicine Technology:Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3
... 19, 2012 The American Medicine Chest Challenge ... campaign preventing prescription drug abuse, announced today, the ... prescription drug collection boxes for the collection of ... The directory created in cooperation with local, county ...
... Md., Jan. 19, 2012  BioElectronics Corporation. (OTC-PINK: BIEL), the ... devices, today announced the acceptance for publication of an ... Journal of Foot and Ankle Surgery. The ... of its medical device on plantar fasciitis. ...
Cached Medicine Technology:National Online Directory of Permanent Prescription Drug Collection Boxes Launched 2BioElectronics' Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: